BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38578380)

  • 21. Anxiety in people with multiple sclerosis during the COVID-19 pandemic: A mixed-methods survey.
    Fahy A; Maguire R
    Rehabil Psychol; 2024 May; 69(2):118-128. PubMed ID: 37956089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities.
    Ul Husnain MI; Hajizadeh M; Ahmad H; Khanam R
    Appl Health Econ Health Policy; 2024 Jul; 22(4):583-598. PubMed ID: 38530626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic.
    Yeni K; Tulek Z; Terzi M
    Mult Scler Relat Disord; 2022 Jan; 57():103370. PubMed ID: 35158434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life under the COVID-19 quarantine.
    Ferreira LN; Pereira LN; da Fé Brás M; Ilchuk K
    Qual Life Res; 2021 May; 30(5):1389-1405. PubMed ID: 33389523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.
    Vogel AC; Schmidt H; Loud S; McBurney R; Mateen FJ
    Mult Scler Relat Disord; 2020 Nov; 46():102512. PubMed ID: 32977074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the working life of people with multiple sclerosis during the COVID-19 pandemic in Sweden.
    Murley C; Dervish J; Machado A; Svärd V; Wennman-Larsen A; Hillert J; Friberg E
    BMC Public Health; 2024 May; 24(1):1389. PubMed ID: 38783221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lockdown on mental health in Australia: evidence from a natural experiment analysing a longitudinal probability sample survey.
    Butterworth P; Schurer S; Trinh TA; Vera-Toscano E; Wooden M
    Lancet Public Health; 2022 May; 7(5):e427-e436. PubMed ID: 35461593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-reported wellbeing and health-related quality of life of Aboriginal and Torres Strait Islander people pre and post the first wave of the COVID-19 2020 pandemic.
    Gall A; Diaz A; Garvey G; Anderson K; Lindsay D; Howard K
    Aust N Z J Public Health; 2022 Apr; 46(2):170-176. PubMed ID: 34939687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life and mental health in multiple sclerosis patients during the COVID-19 Pandemic.
    Rodríguez-Agudelo Y; Nava-Adán J; Paz-Rodríguez F; Abundes-Corona A; Flores-Rivera J; Corona T
    Mult Scler Relat Disord; 2023 Feb; 70():104487. PubMed ID: 36640561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the COVID-19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study.
    Sacre JW; Holmes-Truscott E; Salim A; Anstey KJ; Drummond GR; Huxley RR; Magliano DJ; van Wijngaarden P; Zimmet PZ; Speight J; Shaw JE
    Diabet Med; 2021 Sep; 38(9):e14611. PubMed ID: 34053106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.
    Blakely T; Thompson J; Bablani L; Andersen P; Ait Ouakrim D; Carvalho N; Abraham P; Boujaoude MA; Katar A; Akpan E; Wilson N; Stevenson M
    JAMA Health Forum; 2021 Jul; 2(7):e211749. PubMed ID: 35977202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.
    Siette J; Seaman K; Dodds L; Ludlow K; Johnco C; Wuthrich V; Earl JK; Dawes P; Strutt P; Westbrook JI
    BMC Geriatr; 2021 Jun; 21(1):400. PubMed ID: 34193070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-sectional and temporal differences in health-related quality of life of people with and without osteoarthritis: a 10-year prospective study.
    Zhao T; Ahmad H; Winzenberg T; Aitken D; Graaff B; Jones G; Palmer AJ
    Rheumatology (Oxford); 2021 Jul; 60(7):3352-3359. PubMed ID: 33452525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype.
    Zhang Y; Taylor BV; Simpson S; Blizzard L; Campbell JA; Palmer AJ; van der Mei I
    Mult Scler; 2021 Jul; 27(8):1262-1275. PubMed ID: 32924841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, financial and social impacts of COVID-19 and their associations with mental health for mothers and children experiencing adversity in Australia.
    Bryson H; Mensah F; Price A; Gold L; Mudiyanselage SB; Kenny B; Dakin P; Bruce T; Noble K; Kemp L; Goldfeld S
    PLoS One; 2021; 16(9):e0257357. PubMed ID: 34516564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the COVID-19 Emergency and National Lockdown on Italian Citizens' Economic Concerns, Government Trust, and Health Engagement: Evidence From a Two-Wave Panel Study.
    Graffigna G; Palamenghi L; Savarese M; Castellini G; Barello S
    Milbank Q; 2021 Jun; 99(2):369-392. PubMed ID: 33822424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Intelligent' lockdown, intelligent effects? Results from a survey on gender (in)equality in paid work, the division of childcare and household work, and quality of life among parents in the Netherlands during the Covid-19 lockdown.
    Yerkes MA; André SCH; Besamusca JW; Kruyen PM; Remery CLHS; van der Zwan R; Beckers DGJ; Geurts SAE
    PLoS One; 2020; 15(11):e0242249. PubMed ID: 33253238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis.
    Chiaravalloti ND; Amato MP; Brichetto G; Chataway J; Dalgas U; DeLuca J; Meza C; Moore NB; Feys P; Filippi M; Freeman J; Inglese M; Motl R; Rocca MA; Sandroff BM; Salter A; Cutter G; Feinstein A;
    J Neurol; 2021 May; 268(5):1598-1607. PubMed ID: 32813051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
    Iaffaldano P; Lucisano G; Manni A; Paolicelli D; Patti F; Capobianco M; Brescia Morra V; Sola P; Pesci I; Lus G; De Luca G; Lugaresi A; Cavalla P; Montepietra S; Maniscalco GT; Granella F; Ragonese P; Vianello M; Brambilla L; Totaro R; Toscano S; Malucchi S; Petracca M; Moiola L; Ferraro D; Lepore V; Mosconi P; Ponzio M; Tedeschi G; Comi G; Battaglia MA; Filippi M; Amato MP; Trojano M;
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35046084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study.
    Alirezaei M; Eskandarieh S; Sahraian MA; Naser Moghadasi A
    Neurol Sci; 2022 Jan; 43(1):59-66. PubMed ID: 34554334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.